GBCS SELECTIS HEALTH, INC.

MIXED Impact: 5/10 8-K
Horizon weeks Filed May 7, 2026 Processed 1mo ago SEC 0001493152-26-021783
8-K material event: Items 2.01
Latest settled — T+20d
GBCS ▼ -1.27% at T+20d
NEUTRAL call ✗ call lost -1.27% · α vs SPY -1.30% · entry $3.14 → $3.10
Next anchor: T+60d in 7w
Last close $3.27 (close Jun 12) · +4.14% from $3.14 entry
Entry anchored
May 7, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.23%
$3.14
settled 5w ago
T+5d
+9.87%
call +9.87% · α +8.41%
$3.45
settled 5w ago
T+20d
-1.27%
call -1.27% · α -1.30%
$3.10
settled 10d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Selectis Health completed the sale of two skilled nursing facilities (Glen Eagle and Eastman) for $15.7 million, generating net proceeds of approximately $9 million after mortgage debt repayment, with an additional $1.57 million in escrow potentially releasable. The disposition reduces the company's asset base but provides liquidity and deleveraging.

Actionable Insight

Monitor upcoming pro forma financials for the impact on revenue and earnings. The debt reduction improves balance sheet strength, but the loss of facility income could weigh on future results. Watch for any escrow release or further asset sales.

Key Facts

  • Sold two skilled nursing facilities: Glen Eagle (101 beds) and Eastman (100 beds)
  • Aggregate purchase price of $15.7 million
  • Net proceeds at closing ~$9 million after mortgage debt and other liabilities
  • $1.57 million held in escrow, subject to potential indemnification claims
  • Operations transferred to new operators via Operations Transfer Agreement
  • Pro forma financial statements to be filed by amendment

Financial Impact

$15.7 million gross, ~$9 million net cash proceeds

debtcash

Risk Factors

  • Potential indemnity claims reducing cash proceeds from escrow
  • Reduced future revenue from sold facilities
  • Uncertainty regarding use of remaining proceeds

Market Snapshot

Exchange
OTC
Sector
Real Estate Investment Trusts

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-021783
Exhibit: ex10-2.htm0001493152-26-021783
Exhibit: ex10-5.htm0001493152-26-021783
Document: form8-k.htm0001493152-26-021783
Document: 0001493152-26-021783-index-headers.html0001493152-26-021783
Document: 0001493152-26-021783-index.html0001493152-26-021783
Document: 0001493152-26-021783.txt0001493152-26-021783
3 reports for GBCS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for GBCS — sortable, filterable
Type Now
May 20, 2026
25d ago
8-K
BEARISH ★ 6/10
$3.31 $3.08▲ +6.95%▲ +8.19%$3.27 (+1.21%)
May 7, 2026
5w ago
8-K
MIXED ★ 5/10
$3.14 $3.45▲ +9.87%▲ +8.41%$3.27 (+4.14%)
Mar 19, 2026
12w ago
8-K
NEUTRAL ★ 3/10
$4.05 $4.39▲ +8.40%▲ +10.61%$3.27 (−19.26%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access